Provided by Tiger Fintech (Singapore) Pte. Ltd.

FibroGen

10.35
-0.2800-2.63%
Volume:27.15K
Turnover:285.34K
Market Cap:41.85M
PE:-20.21
High:10.72
Open:10.55
Low:10.31
Close:10.63
52wk High:21.94
52wk Low:4.50
Shares:4.04M
Float Shares:3.62M
Volume Ratio:0.62
T/O Rate:0.75%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5122
EPS(LYR):-11.8895
ROE:-1015.79%
ROA:-16.40%
PB:-0.19
PE(LYR):-0.87

Loading ...

FibroGen Inc expected to post a loss of $2.31 a share - Earnings Preview

Reuters
·
Aug 01

Connect Biopharma Holdings Ltd. Appoints Industry Veteran Jim Schoeneck to Board of Directors, Expanding Leadership Team

Reuters
·
Jul 22

FibroGen Amends Financing Agreement with Morgan Stanley

TIPRANKS
·
Jul 15

FibroGen Inc. Reduces Minimum Cash Balance Requirement in Revised Financing Agreement

Reuters
·
Jul 15

Director Makes Bold Move with Major FibroGen Stock Purchase

TIPRANKS
·
Jul 03

Director James A. Schoeneck Reports Acquisition of Common Shares in FibroGen Inc

Reuters
·
Jul 03

FGEN Enhances Share Capital with Strategic Share Purchase

TIPRANKS
·
Jun 25

FGEN Adjusts Share Capital with Treasury Share Purchase

TIPRANKS
·
Jun 24

FibroGen trading halted, news pending

TIPRANKS
·
Jun 17

FibroGen Enters Relicensing Agreement with HiFiBiO

Dow Jones
·
Jun 14

BRIEF-Fibrogen Inc - On June 12 Enters Termination, Asset Transfer And License Agreement With Hifibio

Reuters
·
Jun 14

FibroGen Inc. Announces 1-for-25 Reverse Stock Split to Boost Share Price

Reuters
·
Jun 13

FibroGen Inc. Appoints Dr. Michael Kauffman to Board of Directors as Part of Strategic Leadership Shift

Reuters
·
Jun 10

FibroGen Inc. Files Initial Beneficial Ownership Statement for Director Michael Kauffman

Reuters
·
Jun 07

FGEN Adjusts Share Capital with Treasury Purchase

TIPRANKS
·
May 21

FibroGen Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
May 13

FibroGen Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 13

FibroGen Q1 EPS $0.05 Beats $0.02 Estimate, Sales $2.74M Beat $2.00M Estimate

Benzinga
·
May 13

FibroGen Inc. Reports Q1 2025 Revenue Drop to $2.7M, Net Loss Narrows to $16.8M, EPS at -$0.16

Reuters
·
May 13

FibroGen Inc expected to post earnings of 2 cents a share - Earnings Preview

Reuters
·
May 10